Targeting CD47: NO limit on therapeutic potential.
Kaczorowski
David J
DJ
Billiar
Timothy R
TR
D000818:Animals; D051928:CD47 Antigen / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D006152:Cyclic GMP / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000235:genetics; D019700:Thrombospondin 1 / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D014652:Vascular Diseases / Q000235:genetics / Q000378:metabolism* / Q000517:prevention & control*
D051928:CD47 Antigen; D019700:Thrombospondin 1; D009569:Nitric Oxide; D006152:Cyclic GMP